PABFX
Price
$19.59
Change
-$0.20 (-1.01%)
Updated
Nov 13 closing price
Net Assets
1.06B
RLBFX
Price
$39.15
Change
-$0.48 (-1.21%)
Updated
Nov 13 closing price
Net Assets
268.67B
Interact to see
Advertisement

PABFX vs RLBFX

Header iconPABFX vs RLBFX Comparison
Open Charts PABFX vs RLBFXBanner chart's image
PGIM Balanced Z
Price$19.59
Change-$0.20 (-1.01%)
VolumeN/A
Net Assets1.06B
American Funds American Balanced R5
Price$39.15
Change-$0.48 (-1.21%)
VolumeN/A
Net Assets268.67B
PABFX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
PABFX vs. RLBFX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABFX is a StrongBuy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 269B vs. PABFX (1.06B). PABFX pays higher dividends than RLBFX: PABFX (2.12) vs RLBFX (1.97). PABFX was incepted earlier than RLBFX: PABFX (33 years) vs RLBFX (24 years). PABFX (0.84) is less costly to investors than RLBFX (0.29). PABFX is a more actively managed with annual turnover of: 107.00 vs. RLBFX (44.00). PABFX has a lower initial minimum investment than RLBFX: PABFX (0) vs RLBFX (250). RLBFX annual gain was more profitable for investors over the last year : 10.28 vs. PABFX (7.70). RLBFX return over 5 years is better than : 43.06 vs. PABFX (29.09).
PABFXRLBFXPABFX / RLBFX
Total Expense Ratio0.780.29269%
Annual Report Gross Expense Ratio0.840.29290%
Fund Existence33 years24 years-
Gain YTD14.85916.50790%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B269B0%
Annual Yield % from dividends2.121.97108%
Returns for 1 year7.7010.2875%
Returns for 3 years42.5144.7495%
Returns for 5 years29.0943.0668%
Returns for 10 years53.2481.3965%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COR363.42-1.66
-0.45%
Cencora
NVRI13.35-0.18
-1.33%
Enviri Corp
DOUG2.61-0.04
-1.51%
Douglas Elliman
CRSP52.19-3.02
-5.47%
CRISPR Therapeutics AG
RBOT4.12-0.45
-9.85%
Vicarious Surgical